FDA to Phase Out Animal Testing for Monoclonal Antibodies and Other Drugs
FDA Approves Biocon Biologics’ Bevacizumab Biosimilar
Teva and Samsung Bioepis Announce U.S. Launch of EPYSQLI® (eculizumab-aagh), a SOLIRIS® Biosimilar
Amgen Files Three IPR Petitions Challenging Bristol-Myers Squibb Anti-PD1 and Anti-CTLA-4 Antibody Combination Method of Treatment Patents
Amgen and Celltrion Settle Denosumab BPCIA Case
Subscribe: Subscribe via RSS
Blogs
Firm/Org